查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1866416

全球血糖值监测设备市场－2025-2030年预测

Global Blood Glucose Monitoring Devices Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球血糖值监测设备市场预计将从 2025 年的 150.86 亿美元成长到 2030 年的 221.77 亿美元，复合年增长率为 8.01%。

受糖尿病患者数量不断增加、健康意识日益增强以及监测解决方案技术进步的推动，全球血糖值监测设备市场预计将稳定成长。这些设备对于糖尿病管理至关重要，能够帮助患者和医护人员追踪血糖值，从而指导他们做出有关药物、饮食和运动的明智决策。对持续、精准监测的需求不断增长，以了解各种因素对糖尿病管理的影响，正是推动市场发展的关键因素。

技术创新显着提升了血糖值监测设备的功能，尤其是携带式血糖仪和连续血糖监测仪（CGM）的出现。血糖仪为患者提供了随时随地监测血糖值的便利性和灵活性。 CGM 每 5 至 15 分钟采集一次数据，能够全面展现血糖值，并支持数据驱动的治疗方案製定。这些进步使得即时追踪和更有效的疾病管理成为可能，从而改善治疗效果，尤其对日益增长的全球 2 型糖尿病患者群体而言更是如此。

市场成长的主要驱动因素是生活方式的改变，例如不健康的饮食习惯、吸烟和饮酒。这些因素导致糖尿病发生率上升，尤其是第2型糖尿病病例的增加预计将推动对监测设备的需求。此外，患者和康復者健康意识的提高也促使他们采用设备进行主动健康管理。医院和医疗机构的需求也推动了这一趋势，他们越来越依赖这些设备来有效监测康復中的患者。

市场按类型、最终用户、分销管道和地区进行细分。按类型划分，市场分为连续血糖监测仪 (CGM) 和自我监测设备，其中 CGM 因其数据准确性高和采集频率高而备受关注。最终用户包括医院和门诊手术中心，医院占据了市场的大部分份额，对可靠的监测工具有着迫切的需求。分销管道分为线上和线下，反映了医疗产品销售中电子商务的日益增长的趋势。从地理来看，市场分布于北美、南美、欧洲、中东和非洲以及亚太地区，并因区域医疗基础设施和糖尿病盛行率的不同而呈现出不同的成长动态。

竞争格局以Medtronic、雅培、BD 和罗氏等主要企业为特征。这些公司正透过产品创新、合作和併购等策略来巩固其市场地位。近期交易和投资凸显了市场的动态性，各公司致力于拓展产品系列併提升技术能力，以满足不断变化的消费者需求。

总体而言，在技术进步、糖尿病盛行率上升和健康意识增强的推动下，血糖值监测市场预计将稳定成长，并成为全球医疗产业的关键细分市场。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024 年）和预测资料（2025-2030 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

第五章血糖值机市场按类型划分

  • 介绍
  • 连续测量装置
  • 自测量装置
  • 瞬时血糖监测（FGM）系统

6. 全球血糖值监测设备市场（依最终用户划分）

  • 介绍
  • 医院
  • 居家医疗
  • 诊所/诊断中心
  • 门诊手术中心
  • 长期照护机构
  • 其他的

7. 全球血糖值监测设备市场（依通路划分）

  • 介绍
  • 在线的
  • 离线

8. 全球血糖值监测设备市场（按地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章：竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十章：公司简介

  • Abbott Laboratories
  • Medtronic plc
  • BD
  • F. Hoffmann-La Roche Ltd.
  • DexCom, Inc.
  • Ascensia Diabetes Care Holdings AG
  • Sanofi SA
  • B. Braun Melsungen AG
  • LifeScan, Inc.
  • Terumo Medical Corporation

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061614014

The Global Blood Glucose Monitoring Devices Market is anticipated to rise from USD 15.086 billion in 2025 to USD 22.177 billion in 2030, fueled by an 8.01% CAGR.

The global blood glucose monitoring devices market is poised for steady growth, driven by the rising prevalence of diabetes, increasing health consciousness, and technological advancements in monitoring solutions. These devices, critical for managing diabetes, enable patients and healthcare providers to track blood sugar levels, facilitating informed decisions on medication, diet, and exercise. The market is fueled by the growing need for continuous and accurate monitoring to understand how various factors impact diabetes management.

Technological innovations have significantly enhanced the functionality of blood glucose monitoring devices, particularly with the advent of portable glucometers and continuous glucose monitors (CGMs). Glucometers allow patients to monitor their blood sugar levels on the go, offering convenience and flexibility. CGMs, which collect readings every 5 to 15 minutes, provide a comprehensive view of glucose trends, enabling data-driven treatment plans. These advancements have improved patient outcomes by allowing real-time tracking and better disease management, particularly for those with type 2 diabetes, which is seeing a global surge.

A key driver of market growth is the shift in lifestyle patterns, characterized by unhealthy habits such as poor diet, smoking, and alcohol consumption, which contribute to the rising incidence of diabetes. This increase in diabetes cases, particularly type 2, is expected to propel demand for monitoring devices. Additionally, growing health awareness among patients and recovered individuals is boosting the adoption of these devices for proactive health management. Hospitals and healthcare institutions are also driving demand, as they increasingly rely on these devices to monitor recovering patients effectively.

The market is segmented by type, end-user, distribution channel, and geography. By type, it is divided into continuous monitoring devices and self-monitoring devices, with CGMs gaining traction due to their precision and frequency of data collection. End-users include hospitals, ambulatory surgical centers, and others, with hospitals being a significant contributor due to their need for reliable monitoring tools. Distribution channels are categorized into online and offline, reflecting the growing trend of e-commerce in healthcare product sales. Geographically, the market spans North America, South America, Europe, the Middle East and Africa, and the Asia Pacific, with varying growth dynamics based on regional healthcare infrastructure and diabetes prevalence.

The competitive landscape features major players such as Medtronic plc, Abbott Laboratories, BD, and F. Hoffmann-La Roche Ltd. These companies are pursuing strategies like product innovation, partnerships, and mergers to strengthen their market position. Recent deals and investments highlight the dynamic nature of the market, with firms focusing on expanding their product portfolios and enhancing technological capabilities to meet evolving consumer needs.

Overall, the blood glucose monitoring devices market is set to grow steadily, driven by technological advancements, increasing diabetes prevalence, and heightened health awareness, positioning it as a critical segment in the global healthcare industry.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

The Blood Glucose Monitoring Devices Market is analyzed into the following segments:

By Type

  • Continuous Monitoring Devices
  • Self-Monitoring Devices
  • Flash Glucose Monitoring (FGM) Systems

By End-User

  • Hospitals
  • Home Care Settings
  • Clinics/Diagnostic Centers
  • Ambulatory Surgical Centers
  • Long-Term Care Facilities
  • Others

By Distribution Channel

  • Online
  • Offline

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Continuous Monitoring Devices
  • 5.3. Self-Monitoring Devices
  • 5.4. Flash Glucose Monitoring (FGM) Systems

6. GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Hospitals
  • 6.3. Home Care Settings
  • 6.4. Clinics/Diagnostic Centers
  • 6.5. Ambulatory Surgical Centers
  • 6.6. Long-Term Care Facilities
  • 6.7. Others

7. GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET BY DISTRIBUTION CHANNEL

  • 7.1. Introduction
  • 7.2. Online
  • 7.3. Offline

8. GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Abbott Laboratories
  • 10.2. Medtronic plc
  • 10.3. BD
  • 10.4. F. Hoffmann-La Roche Ltd.
  • 10.5. DexCom, Inc.
  • 10.6. Ascensia Diabetes Care Holdings AG
  • 10.7. Sanofi S.A.
  • 10.8. B. Braun Melsungen AG
  • 10.9. LifeScan, Inc.
  • 10.10. Terumo Medical Corporation

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations